![Jörn Drappa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörn Drappa
Direttore Tecnico/Scientifico/R&S presso
ALUMIS INC.
Patrimonio netto: 2 M $ in data 30/06/2026
Profilo
Jörn Drappa was the founder of Viela Bio, Inc., founded in 2018, where the title held was Chief Medical Officer, Head-Research & Development from 2018 to 2021.
The current job is Chief Medical Officer at Alumis, Inc. starting in 2022.
Former jobs include Associate Director-Medical at Amgen, Inc. from 2003 to 2006; Senior Medical Director at Genentech, Inc. from 2008 to 2011; Vice President-Clinical Development at MedImmune LLC from 2011 to 2018; Executive Vice President-Research & Development at Horizon Therapeutics Ltd. (Ireland) in 2021; Chief Medical Officer at Ventyx Biosciences, Inc. from 2021 to 2022; and Director at Alpine Immune Sciences, Inc. from 2022 to 2024.
Education includes a doctorate from Universität zu Köln conferred in 1991 and a doctorate from Weill Cornell Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ALUMIS INC. 0,05% | 22/05/2026 | 59.339 ( 0,05% ) | 2 M $ | 30/06/2026 |
Posizioni attive di Jörn Drappa
| Società | Posizione | Inizio |
|---|---|---|
| ALUMIS INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2022 |
Precedenti posizioni note di Jörn Drappa
| Società | Posizione | Fine |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Direttore/Membro del Consiglio | 20/05/2024 |
| VENTYX BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 05/05/2022 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Direttore Tecnico/Scientifico/R&S | 01/09/2021 |
| VIELA BIO, INC. | Fondatore | 15/03/2021 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direttore Tecnico/Scientifico/R&S | 01/02/2018 |
Formazione di Jörn Drappa
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
81
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
Weill Cornell Medicine
 Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
